Guo Liang, Zhou Shui-Rong, Wei Xiang-Bo, Liu Yuan, Chang Xin-Xia, Liu Yang, Ge Xin, Dou Xin, Huang Hai-Yan, Qian Shu-Wen, Li Xi, Lei Qun-Ying, Gao Xin, Tang Qi-Qun
Key Laboratory of Metabolism and Molecular Medicine, Ministry of Education, and Department of Biochemistry and Molecular Biology, Fudan University Shanghai Medical College, Shanghai, People's Republic of China.
Department of Endocrinology and Metabolism, Fudan University Zhongshan Hospital, Shanghai, People's Republic of China.
Mol Cell Biol. 2016 Sep 26;36(20):2553-67. doi: 10.1128/MCB.00227-16. Print 2016 Oct 15.
Nonalcoholic fatty liver disease (NAFLD) has become the most common liver disease, and decreased fatty acid oxidation is one of the important contributors to NAFLD. Mitochondrial trifunctional protein α-subunit (MTPα) functions as a critical enzyme for fatty acid β-oxidation, but whether dysregulation of MTPα is pathogenically connected to NAFLD is poorly understood. We show that MTPα is acetylated at lysine residues 350, 383, and 406 (MTPα-3K), which promotes its protein stability by antagonizing its ubiquitylation on the same three lysines (MTPα-3K) and blocking its subsequent degradation. Sirtuin 4 (SIRT4) has been identified as the deacetylase, deacetylating and destabilizing MTPα. Replacement of MTPα-3K with either MTPα-3KR or MTPα-3KQ inhibits cellular lipid accumulation both in free fatty acid (FFA)-treated alpha mouse liver 12 (AML12) cells and primary hepatocytes and in the livers of high-fat/high-sucrose (HF/HS) diet-fed mice. Moreover, knockdown of SIRT4 could phenocopy the effects of MTPα-3K mutant expression in mouse livers, and MTPα-3K mutants more efficiently attenuate SIRT4-mediated hepatic steatosis in HF/HS diet-fed mice. Importantly, acetylation of both MTPα and MTPα-3K is decreased while SIRT4 is increased in the livers of mice and humans with NAFLD. Our study reveals a novel mechanism of MTPα regulation by acetylation and ubiquitylation and a direct functional link of this regulation to NAFLD.
非酒精性脂肪性肝病(NAFLD)已成为最常见的肝脏疾病,脂肪酸氧化减少是NAFLD的重要促成因素之一。线粒体三功能蛋白α亚基(MTPα)作为脂肪酸β氧化的关键酶,但MTPα的失调是否与NAFLD的发病机制相关尚不清楚。我们发现MTPα在赖氨酸残基350、383和406处被乙酰化(MTPα-3K),这通过拮抗其在相同三个赖氨酸上的泛素化(MTPα-3K)并阻止其随后的降解来促进其蛋白质稳定性。沉默调节蛋白4(SIRT4)已被鉴定为去乙酰化酶,可使MTPα去乙酰化并使其不稳定。用MTPα-3KR或MTPα-3KQ替代MTPα-3K可抑制游离脂肪酸(FFA)处理的α小鼠肝脏12(AML12)细胞和原代肝细胞以及高脂/高糖(HF/HS)饮食喂养小鼠肝脏中的细胞脂质积累。此外,敲低SIRT4可模拟MTPα-3K突变体在小鼠肝脏中的表达效果,并且MTPα-3K突变体更有效地减轻HF/HS饮食喂养小鼠中SIRT4介导的肝脂肪变性。重要的是,在患有NAFLD的小鼠和人类肝脏中,MTPα和MTPα-3K的乙酰化均降低,而SIRT4增加。我们的研究揭示了一种通过乙酰化和泛素化调节MTPα的新机制,以及这种调节与NAFLD的直接功能联系。